Table 1.
Author | Year | Country | microRNAs | Regulation mode | Sample size | Speci-men | Diagnostic power | |||
---|---|---|---|---|---|---|---|---|---|---|
MM | Healthy | Sen (%) | Spe (%) | AUC | ||||||
Single miRNA | ||||||||||
Kubiczkova, L.[23] | 2014 | Czech Republic | let-7d | Downregulated | 103 | 30 | Serum | 0.641 | 0.867 | 0.804 |
Kubiczkova, L.[23] | 2014 | Czech Republic | let-7e | Downregulated | 103 | 30 | Serum | 0.888 | 0.633 | 0.829 |
Li, J.[24] | 2020 | China | miR-15a-5p | Upregulated | 23 | 18 | Serum | 0.870 | 0.610 | 0.804 |
Li, F.[25] | 2015 | China | miR-16–1 | Downregulated | 90 | 19 | Plasma | 1.000 | 0.730 | 0.864 |
Hao, M.[26] | 2015 | China | miR-19a | Upregulated | 108 | 56 | Serum | 0.773 | 0.897 | 0.910 |
Qiu, X. Y.[27] | 2013 | China | miR-20a | Downregulated | 40 | 20 | Plasma | 0.63 | 0.85 | 0.74 |
Sevcikova, S.[28] | 2013 | Czech Republic | miR-29a | Upregulated | 91 | 30 | Serum | 0.880 | 0.700 | 0.832 |
Xu, Y. N.[29] | 2017 | China | miR-29a | Upregulated | 40 | 20 | Serum | 0.815 | 0.722 | 0.763 |
Kubiczkova, L.[23] | 2014 | Czech Republic | miR-34a | Upregulated | 103 | 30 | Serum | 0.777 | 0.700 | 0.790 |
Yoshizawa, S.[19] | 2012 | Japan | miR-92a | Downregulated | 62 | 133 | Plasma | 0.919 | 0.991 | 0.981 |
Hao, M.[26] | 2015 | China | miR-92a | Upregulated | 108 | 56 | Serum | 0.724 | 0.869 | 0.830 |
Jiang, Y.[30] | 2018 | China | miR-125b-5p | Upregulated | 35 | 20 | Plasma | 0.860 | 0.960 | 0.954 |
Kubiczkova, L.[23] | 2014 | Czech Republic | miR-130a | Downregulated | 103 | 30 | Serum | 0.575 | 0.900 | 0.722 |
Li, J.[24] | 2020 | China | miR-134-5p | Upregulated | 23 | 18 | Serum | 0.870 | 0.667 | 0.812 |
Hao, M.[26] | 2015 | China | miR-135b-5p | Upregulated | 108 | 56 | Serum | 0.667 | 0.833 | 0.810 |
Nidhi Gupta.[21] | 2019 | Germany | miR-143 | Upregulated | 30 | 30 | Serum | 0.767 | 0.767 | 0.854 |
Nidhi Gupta.[21] | 2019 | Germany | miR-144 | Upregulated | 30 | 30 | Serum | 0.733 | 0.733 | 0.784 |
Xie, L. L. [31] | 2018 | China | miR-148a | Upregulated | 50 | 30 | Serum | 0.760 | 0.700 | 0.791 |
Xu, Y. N.[29] | 2017 | China | miR-155 | Downregulated | 40 | 20 | Serum | 0.800 | 0.722 | 0.862 |
Nidhi Gupta.[21] | 2019 | Germany | miR-199 | Upregulated | 30 | 30 | Serum | 0.800 | 0.800 | 0.90 |
Nidhi Gupta.[21] | 2019 | Germany | miR-203 | Upregulated | 30 | 30 | Serum | 0.833 | 0.833 | 0.930 |
Jiang, Y.[30] | 2018 | China | miR-490-3p | Upregulated | 35 | 20 | Plasma | 0.600 | 0.850 | 0.866 |
Cai, L.[32] | 2019 | China | miR-497 | Downregulated | 63 | 50 | Serum | 0.860 | 0.960 | 0.933 |
Jones, C. I.[33] | 2012 | UK | miR-720 | Upregulated | 24 | 13 | Serum | 0.872 | 0.923 | 0.911 |
Kubiczkova, L.[23] | 2014 | Czech Republic | miR-744 | Downregulated | 103 | 30 | Serum | 0.728 | 0.667 | 0.715 |
Jones, C. I.[33] | 2012 | UK | miR-1308 | Downregulated | 24 | 13 | Serum | 0.821 | 0.923 | 0.892 |
Hao, M.[26] | 2015 | China | miR-4254 | Upregulated | 108 | 56 | Serum | 0.793 | 0.985 | 0.920 |
Shen, X.[34] | 2017 | China | miR-4449 | Upregulated | 71 | 64 | Serum | 0.789 | 0.913 | 0.885 |
miRNA cluster | ||||||||||
Hao, M.[26] | 2015 | China | miR-19a + miR-4254 | Upregulated | 108 | 56 | Serum | 0.917 | 0.905 | 0.950 |
Liu, B.[35] | 2015 | China | miR-21/miR-199b-5p | Upregulated | 24 | 30 | Serum | 0.960 | 1.000 | 0.990 |
Xu, Y. N.[29] | 2017 | China | miR-29a/miR-155 | Upregulated | 40 | 20 | Serum | 0.808 | 0.833 | 0.874 |
Kubiczkova, L.[23] | 2014 | Czech Republic | miR-34a + let-7e | Upregulated | 103 | 30 | Serum | 0.806 | 0.867 | 0.898 |